Molecular epidemiology of atherosclerosis

FASEB Journal

Volumn 11, Issue 12, 1997, Pages 1021-1031

  De Flora, Silvio ^d   Izzotti, Alberto ^e   Walsh, Debra ^a   Degan, Paolo ^b   Petrilli, Gian Luigi ^c   Lewtas, Joellen ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c GALLIERA HOSPITAL   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e OEA 095 ^*

Author keywords

Aging; Cigarette smoke; DNA adducts; Dyslipidosis; Hypertension; Oxidative DNA damage; Smooth muscle cells

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; DNA ADDUCT; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; PRIORITY JOURNAL; RISK FACTOR; SMOOTH MUSCLE FIBER; SPECTROFLUOROMETRY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030771834     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.12.9337155     Document Type: Article

References (63)

1. World Health Organization (1985) Classification of atherosclerotic lesions. WHO Tech. Rep. Serv. 143, 1-20
2. Ross, R. E. (1993) Rous-Whipple Award Lecture: Atherosclerosis: A defense mechanism gone awry. Am. J. Pathol. 143, 987-1002
3. Ramos, K. S., Chacon, E., and Acosta, D., Jr. (1996) Toxic responses of the heart and vascular systems. In Casarett and Doull's Toxicology. The Basic Science of Poisons (Klaassen, C. D., ed) pp. 487-527, McGraw-Hill, New York
4. Ross, R. E. (1993) The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature (London) 362, 801-809
5. Trosko, J., and Chang, C. (1980) An integrative hypothesis linking cancer, diabetes, and atherosclerosis: The role of mutations and epigenetic changes. Med. Hypoth. 6, 455-468
6. Bridges, B. A., Bowyer, D. E., Hansen, E. S., Penn, A., and Wakabayashi, K. (eds) (1990) Report of ICPEMC Subcommittee 7/ 1. The possible involvement of somatic mutations in the development of atherosclerotic plaques (special issue). Mutat. Res. 239, 143-187
7. Benditt, E. P., and Benditt, J. M. (1973) Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl Acad. Sci. USA 70, 1753-1756
8. Penn, A., Garte, S. J., Warren, L., Nesta, D., and Mindich, B. (1986) Transforming gene in human atherosclerotic plaque DNA. Proc. Natl Acad. Sci. USA 83, 7951-7955
9. Penn A., Hubbard, F. C., Jr., and Parkes, J. L. (1991) Transforming potential is detectable in arteriosclerotic plaques of young animals. Arterioscler. Thromb. 11, 1053-1058
10. Gordon, D., Reidy, M. A., Benditt, E. P., and Schwartz, S. M. (1990) Cell proliferation in human coronary arteries. Proc. Natl Acad. Sci. USA 87, 4600-4604
11. Ross, R. E. (1986) The pathogenesis of atherosclerosis - An update. New Engl. J. Med. 314, 488-500
12. Grainger D. J., Kirschenlohr, H. L., Metcaffe, J. C., Weissberg, P. L., Wade, D. P., and Lawn, R. M. (1993) Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 260, 1655-1658
13. Izzotti, A., De Flora, S., Petrilli, G. L., Gallagher, A., Rojas, M., Alexandrov, K., Bartsch, H., and Lewtas, J. (1995) Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts. Cancer Epidemol. Biomarkers Prev. 4, 105-110
14. D'Agostini, F., Fronza, G., Campomenosi, P., Izzotti, A., Petrilli, G. L., Abbondandolo, A., and De Flora, S. (1995) Cancer biomarkers in human atherosclerotic lesions. II. No evidence of p53 involvement. Cancer. Epidem. Biomarkers. Prev. 4, 111-115
15. Izzotti, A., D'Agostini, F., Bagnasco, M., Rovida, A., Balansky, R. M., Cesarone, C. F., and De Flora, S. (1994) Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases. Cancer Res. 54, (Suppl.), 1994s-1998s
16. 32P-posdabeling assay. J. Natl Cancer Inst. 81, 341-347
17. Lewtas, J., Walsh, D., Inmon, J., Curik, R., and Dobiàs, L. (1995) Distribution of DNA adducts in human cardiopulmonary autopsy tissues. Proc. 86th Annu. Meet. Am. Assn. Cancer Res. 36, 652 (abstr.)
18. Gupta, R. C. (1984) Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc. Natl Acad. Sci. USA 81, 6943-6947
19. Clausen, J. (1993) Comparison of DNA adduct formation by means of synchronous scanning and by isotope tracers: in vitro study on formation of DNA adducts in human lymphocytes exposed to benzo(a)pyrene. Cancer Lett. 72, 163-167
20. Lewtas, J., Mumford, J., Everson, R. B., Hulka, B., Wilcosky, T., Kozumbo, W., Thompson, C., George, M., Dobias, L., Sram, R., Li, X., and Gallagher, J. (1993) Comparison of DNA adducts from complex mixture exposures in various human tissues and experimental systems. Environ. Hlth Perspect. 99, 88-97
21. 32P-postlabeling analysis of non-radioactive aromatic carcinogen DNA adducts. Carcinogenesis 2, 1081-1092
22. Vähäkangas, K., Pelkonen, O., and Harris, C. C. (1988) Synchronous fluorescence spectrophotometry of benzo(a)pyrene diolepoxide-DNA adducts: a tool for the detection of in-vitro and in-vivo DNA damage by exposure to benzo(a)pyrene. In Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention (Bartsch, H., Hemminki, K., and O'Neill, I. K., eds) pp. 208-212. IARC Sci. Publ. No. 89, International Agency for Research on Cancer, Lyon, France
23. Izzotti, A., Balansky, R., Coscia, N., Scatolini, L., D'Agostini, F., and De Flora, S. (1992) Chemoprevention of smoke-related DNA adduct formation in rat lung and heart. Carcinogenesis 13, 2187-2190
24. Degan, P., Bonassi, S., De Caterina, M., Korkina, L. G., Scopacasa, F., Zatterale, A., Calzone, R., and Pagano, G. (1995) In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 16, 735-741
25. Degan, P., Shigenaga, M. K., Park, J.-W., Alperin, P. E., and Ames, B. N. (1991) Immunoaffinity isolation of urinary 8-hydroxy-2′-deoxyguanosine and 8-hydroxyguanine and quantitation of 8-hydroxy-2′-deoxyguanosine in DNA by polyclonal antibodies. Carcinogenesis 12, 865-871
26. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1984) The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch. Int. Med. 144, 1045-1057
27. Izzotti, A., Rossi, G. A., Bagnasco, M., and De Flora, S. (1991) Benzo(a)pyrene diolepoxide-DNA adducts in alveolar macrophages of smokers. Carcinogenesis 12, 1281-1285
28. Bashir, S., Harris, G., Denman, M. A., Blake, D. R., and Winyard, P. G. (1993) Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann. Rheum. Dis. 52, 659-666
29. Shimoda, R., Nagashima, M., Sakamoto, M., Yamaguchi, N., Hirohashi, S., Yokota, J., and Kasai, H. (1994) Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res. 54, 3171-3172
30. Mecocci, P., MacGarvey, U., and Beal, M. F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-751
31. Baik, S.-C., Youn, H.-S., Chung, M.-H., Lee, W.-K., Cho, M.-J., Ko, J.-H., Park, C.-K., Kasai, H., and Rhee, K.-H. (1996) Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer. Res. 56, 1279-1282
32. Crawford, D. W., and Blankenhorn, D. H. (1991) Arterial wall oxygenation, oxyradicals, and atherosclerosis. Atherosclerosis 89, 97-108
33. Park, J.-W., and Floyd, R. A. (1992) Lipid peroxidation products mediate the formation of 8-hydroxydeoxyguanosine in DNA. Free Rad. Biol. Med. 12, 245-250
34. Randerath, K., Chang, J., and Randerath, E. (1995) Age-dependent DNA modifications (I-compounds): Effects of carcinogenesis and oxidative stress. In Oxidative Stress and Aging (Cutler, R. G., Packer, L., Bertram, J., and Mori, A., eds) pp. 77-87, Birkhauser Verlag, Basel, Switzerland
35. Ames, B. N. (1983) Dietary carcinogens and anticarcinogens. Science 221, 1256-1263
36. Duthie, K., Wahle, K. W. J., and James, W. P. T. (1989) Oxidants, antioxidants and cardiovascular disease. Nutr. Res. Rev. 2, 51-62
37. Randerath, E., Zhou, G.-d., Hart, R. W., and Randerath, K. (1995) Age-dependent indigenous covalent DNA modifications (I-compounds). In Dietary Restriction: Implications for the Design and Interpretation of Toxicity and Carcinogenicity Studies (Hart, R. W., Neumann, D. A., and Robertson, R. T., eds) pp. 229-244, ILSI Press, Washington, D.C.
38. Thirman, M. J, Albrecht, J. H., Krueger, M. A., Erikson, R. R., Cherwitz, D. L., Park, S. S., Gelboin H. V., and Holtzman, J. L. (1994) Induction of cytochrome CYPIA1 and formation of toxic metabolites of benzopyrene by rat aorta: a possible role in atherogenesis. Proc. Natl Acad. Sci. USA 91, 5397-5401
39. Bond, J. A., Kocan, R. M., Benditt, E. P., and Juchau, M. R. (1979) Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured human fetal aortic smooth muscle cells. Life Sci. 25, 425-430
40. Zwijsen, R. M. L., van Kleef, E. M., and Alink, G. M. (1990) A comparative study on the metabolic activation of benzo[a]pyrene to mutagens by aorta smooth muscle cells of rat and rabbit. Mutat. Res. 230, 111-117
41. Hogg, S. I., and Cryer, A. (1982) Aortic arylhydrocarbon hydroxylase activity in atherosclerosis-susceptible and atherosclerosis-resistant species. Comp. Biochem. Physiol. 73b, 669-671
42. Paigen, B., Holmes, P. A., Morrow, A., and Mitchell, D. (1986) Effect of 3-methylcholanthrene on atherosclerosis in two congenic strains of mice with different susceptibilities to methylcholanthrene-induced tumors. Cancer Res. 46, 3321-3324
43. Penn, A., and Snyder, C. (1988) Arteriosclerotic plaque development is "promoted" by polynuclear aromatic hydrocarbons. Carcinogenesis 9, 2185-2189
44. Majesky, M. W., Reidy, M. A., Benditt, E. P., Juchau, M. R. (1985) Focal smooth muscle proliferation in the aortic intima produced by an initiation-promotion sequence. Proc. Natl Acad. Sci. USA 82, 3450-3454
45. Busbee, D. I., Rankin, I. W., Pain, D. M., and Jasheway, D. W. (1982) Binding of benzo[a]pyrene and intracellular transport of a bound electrophilic benzo[a]pyrene metabolite by lipoproteins. Carcinogenesis 3, 1107-1112
46. Ou, X., Weber, T. J., Chapkin, R. S., and Ramos, K. S. (1995) Interference with protein kinase C-related signal transduction in vascular smooth muscle cells by benzo[a]pyrene. Arch. Biochem. Biophys. 760, 354-356
47. Kannel, W. B. (1981) Update on the role of cigarette smoking in coronary artery diseases. Am. Heart. J. 101, 319-328
48. Hansen, E. S. (1990) Shared risk factors for cancer and atherosclerosis - A review of the epidemiological evidence. Mutat. Res. 239, 163-179
49. International Agency for Research on Cancer (1986) Tobacco smoking. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Vol. 38, International Agency for Research on Cancer, Lyon, France
50. Smith, L. L. (1981) Distribution of autoxidation products. In Cholesterol Autoxidation. (Smith, L. L., ed) pp. 49-124, Plenum Press, New York
51. Peng, S. K., Taylor, C. B., Tham, P., Werthessen, N. T., and Mikkelson, B. (1989) Effect of autoxidation products from cholesterol on aortic smooth muscle cells. Arch. Pathol. Lab. Med. 102, 57-61
52. Imai, H., Werthessen, N. T., Subramanyam, V., Le-Quesne, P. W., Soloway, A. H., and Kanisawa, M. (1980) Angiotoxicity of oxygenated sterols and possible precursors. Science 207, 651-653
53. Sevanian, A., and Peterson, A. R. (1986) The cytotoxicity and mutagenic properties of cholesterol oxidation products. Food Chem. Toxicol. 24, 1103-1110
54. Kendall, C. W., Koo, M., Sokoloff, E., and Rao, A. V. (1992) Effect of dietary oxidized cholesterol on azoxymethane-induced colonic preneoplasia in mice. Cancer Lett. 76, 241-248
55. Zwijsen, R. M. L. (1992) Cell-transforming potential of low-density lipoproteins. Carcinogenesis 13, 1913-1915
56. Burchfiel, C. M., Laws, A., Benfante, R., Goldberg, R. J., Hwang, L.-J., Chiu, D., Rodriguez, B. L., Curb, J. D., and Sharp, D. S. (1995) Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation 92, 1430-1436
57. Yoshida, Y., Sue, W., Okano, M., Oyama, T., Yamane, T., and Mitsumata, M. (1990) The effects of augmented hemodynamic forces on the progression and topography of atherosclerotic plaques. Ann. N.Y. Acad. Sci. 598, 256-273
58. Chobanian, A. V. (1990) 1989 Corcoran Lecture: Adaptive and maladaptive responses of the artherial wall to hypertension. Hypertension 15, 666-674
59. Zhang, Y., and Ramos, K. S. (1997) The induction of proliferative vascular smooth muscle cell phenotypes by benzo(a)pyrene does not involve mutational activation of ras genes. Mutat. Res. 373, 285-292
60. Bogliolo, M., Fronza, G., Campomenosi, P., Assereto, P., Izzotti, A., Petrilli, G. L., Abbondandolo, A., and De Flora, S. (1996) Cancer biomarkers in human atherosclerotic lesions. Lack of mutations in K-ras codons 12 and 13. Chem.-Biol. Int. 102, 55-62
61. Indolfi, C., Avvedimento, E. V., Rapacciuolo, A., Di Lorenzo, E., Esposito, G., Stabile, E., Felicello, A., Mele, E., Giuliano, P., Condorelli, C., and Chiariello, M. (1995) Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med. 1, 541-545
62. Parkes, J. L., Cardell, R. R., Hubbard, F. C., Jr., Hubbard, D., Meltzer, A., and Penn, A. (1991) Cultured human atherosclerotic plaque smooth muscle cells retained transforming potential and display enhanced expression of the myc protooncogene. Am. J. Pathol. 138, 765-775
63. Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., and Epstein, S. E. (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265, 391-394